1.
Flowers CR, Matasar MJ, Herrera AF, Hertzberg M, Assouline S, Demeter J, McMillan A, Mehta A, Opat S, Trnňný M, Musick L, Hirata J, Yang A, Sehn LH. Polatuzumab vedotin plus bendamustine and rituximab or obinutuzumab in relapsed/refractory follicular lymphoma: a phase Ib/II study. haematol [Internet]. 2024Mar.31 [cited 2024Apr.12];109(4):1194-205. Available from: https://haematologica.org/article/view/haematol.2023.283557